Health news round-up: new cancer drugs, pharmacogenomics, and whether GLP-1s cause erectile dysfunction Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Paxlovid speeds COVID-19 recovery but does not reduce hospital admissions Across two trials, more than 4,000 patients were randomised to receive usual care or Paxlovid (nirmatrelvir and ritonavir; Pfizer) within three or four days of symptom onset.…
Investigational anti-clotting drug reduced stroke risk by more than one-quarter, study finds Researchers observed a 17% reduction in major cardiovascular events in patients who took asundexian compared with the placebo group.…
Gabapentinoids found to increase risk of drug toxicity Researchers found that patients taking gabapentinoids with benzodiazepines were at double the risk of being hospitalised with drug poisoning, while combining the drug with opioids has a 30% increase in risk.…
Health news round-up: semaglutide and liver health, obesity vaccine response and hope for pancreatic cancer Our weekly summary of the important developments in pharmacy and health news you may have missed.…
Manufacturer to warn of fatal adverse reactions from blood-clotting drug and anaesthetic mix-ups A letter from Pfizer cautions healthcare professionals to use extreme caution when storing, handling and administrating IV formulations of tranexamic acid.…
Health news round-up: dementia, GLP-1 genetics and psychedelics breakthrough Our weekly summary of the important developments in pharmacy and health news you may have missed.…
The history of the Royal Pharmaceutical Society Highlighting the historical high points that have so far defined the Royal Pharmaceutical Society, which was first established in 1841.…
Dysaesthesia added to semaglutide side effects list Abnormal and unpleasant touch-based sensations are now listed as a “common” adverse reaction to Rybelsus.…
News round-up: long COVID, chikungunya and free supplies of ciprofloxacin Our weekly summary of the important developments in pharmacy and health news you may have missed.…
